Cargando…

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

Human papillomavirus (HPV) types 16 and 18 cause 70% of cervical cancer cases globally. The nonavalent HPV vaccine (9vHPV) was licensed in 2014 and protects against the next five most common cancer-causing HPV types (HPV 31/33/45/52/58) after HPV 16/18. Phase III clinical studies have demonstrated h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toh, Zheng Quan, Kosasih, Jennie, Russell, Fiona M, Garland, Suzanne M, Mulholland, Edward K, Licciardi, Paul V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613616/ https://www.ncbi.nlm.nih.gov/pubmed/31308715 http://dx.doi.org/10.2147/IDR.S178381

Ejemplares similares

Human Papillomavirus Vaccination After COVID-19
por: Toh, Zheng Quan, et al.
Publicado: (2021)

Australia’s Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific
por: Toh, Zheng Quan, et al.
Publicado: (2021)

Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult
por: Ferguson, Sara B., et al.
Publicado: (2017)

Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination
por: Pizzatti, Laura, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method
por: Toh, Zheng Quan, et al.
Publicado: (2020)

Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
por: Forster, Alice S., et al.
Publicado: (2016)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination
por: Batmunkh, Tsetsegsaihan, et al.
Publicado: (2020)

Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series
por: BOSSART, Simon, et al.
Publicado: (2020)

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
por: Patel, Cyra, et al.
Publicado: (2018)

Human papillomavirus vaccination: the population impact
por: Lee, Lai-yang, et al.
Publicado: (2017)

Cervical Cancer Prevention Through HPV Vaccination in Low- and Middle-Income Countries in Asia
por: Toh, Zheng Quan, et al.
Publicado: (2017)

Human papillomavirus vaccination: where to now?
por: Garland, S M
Publicado: (2011)

Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
por: Sias, Catia, et al.
Publicado: (2020)

Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men
por: Poynten, I. Mary, et al.
Publicado: (2017)

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
por: Brown, Darron R., et al.
Publicado: (2022)

Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
por: Choi, Horace C. W., et al.
Publicado: (2018)

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
por: Toh, Zheng Quan, et al.
Publicado: (2019)

The Cape Town declaration on human papillomavirus related disease()
por: Williamson, Anna-Lise, et al.
Publicado: (2017)

Evidence of recombination within human alpha-papillomavirus
por: Angulo, Manuel, et al.
Publicado: (2007)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students
por: Deriemaeker, Hanne, et al.
Publicado: (2014)

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region()
por: Castellsagué, Xavier, et al.
Publicado: (2016)

Human papillomavirus: The disease and prevention strategies
por: Akhtar, Mohammed
Publicado: (2004)

Human Papillomavirus Prevention by Vaccination: A Review Article
por: Charde, Samruddhi H, et al.
Publicado: (2022)

Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution
por: Rungmaitree, Supattra, et al.
Publicado: (2022)

Human Papillomavirus Vaccination Strategies
por: Cachafeiro, Santiago Pérez
Publicado: (2007)

Vaccination against human papillomavirus
por: Mello, Claudia Figueiredo
Publicado: (2013)

Human Papillomavirus and Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2020)

Recombination Between High-Risk Human Papillomaviruses and Non-Human Primate Papillomaviruses: Evidence of Ancient Host Switching Among Alphapapillomaviruses
por: Murahwa, Alltalents T., et al.
Publicado: (2020)

Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia
por: Tung, Iris L. Y., et al.
Publicado: (2016)

Using Facebook to Recruit Young Australian Men Into a Cross-Sectional Human Papillomavirus Study
por: Das, Roopa, et al.
Publicado: (2017)

Anal human papillomavirus prevalence and risk factors among men who have sex with men in Vietnam
por: Tuan, Le Anh, et al.
Publicado: (2021)

Adolescent Male Human Papillomavirus Vaccination
por: Nanagas, Vivian C., et al.
Publicado: (2016)

Single-dose nonavalent HPV vaccine: Need of the hour
por: Pal, Manidip, et al.
Publicado: (2020)

Vaccination to prevent human papillomavirus infections: From promise to practice
por: Bloem, Paul, et al.
Publicado: (2017)

Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population
por: Amboree, Trisha L., et al.
Publicado: (2022)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
por: Garland, Suzanne M., et al.
Publicado: (2022)

Knowledge of Cervical Cancer and Acceptability of Prevention Strategies Among Human Papillomavirus-Vaccinated and Human Papillomavirus-Unvaccinated Adolescent Women in Eldoret, Kenya
por: Mburu, Anisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sigb3n0bebsbbnsg2htd0ddb80